Sofosbuvir improves HCV-induced insulin resistance by blocking IRS1 degradation.
Rey E, Ampuero J, Molina-Jiménez F, Marañón P, García-García Y, Múñoz-Hernández R, Romero-Gómez M, García-Monzón C, Majano P, González-Rodríguez Á.
Rey E, et al.
Clin Transl Med. 2021 Jan;11(1):e275. doi: 10.1002/ctm2.275.
Clin Transl Med. 2021.
PMID: 33463051
Free PMC article.
No abstract available.